Cetera Trust Company’s Colgate-Palmolive CL Stock Holding History

Cetera Trust Company’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34.1K	Sell	400 -600	-60%	-$54.3K	0.02%	234
2026 Q2	$91.7K	Hold	1,000	–	–	0.05%	208
2026 Q1	$85.2K	Hold	1,000	–	–	0.05%	203
2025 Q4	$79K	Hold	1,000	–	–	0.04%	203
2025 Q3	$79.9K	Hold	1,000	–	–	0.04%	209
2025 Q2	$90.9K	Hold	1,000	–	–	0.05%	205
2025 Q1	$93.7K	Hold	1,000	–	–	0.06%	199
2024 Q4	$90.9K	Hold	1,000	–	–	0.06%	200
2024 Q3	$104K	Hold	1,000	–	–	0.06%	203
2024 Q2	$97K	Hold	1,000	–	–	0.06%	207
2024 Q1	$90K	Hold	1,000	–	–	0.05%	208
2023 Q4	$79.7K	Buy	+1,000	New	+$75.2K	0.05%	212

Other funds holding CL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Cetera Trust Company's CL Position: Q3 2026 in Review

Cetera Trust Company reduced its Colgate-Palmolive (CL) stake by 60% in Q3 2026, selling an estimated $54.3K and leaving 400 shares worth $34.1K. The position accounts for 0.02% of the portfolio, ranked #234.

Cetera Trust Company first reported a position in CL in Q4 2023 and has held it in 12 quarters since. The position peaked at $104K in Q3 2024. 1,322 funds tracked by Wall St. Rank hold CL as of Q3 2026.

Cetera Trust Company held 400 shares of Colgate-Palmolive worth $34.1K as of Q3 2026.
Cetera Trust Company sold 600 Colgate-Palmolive shares in Q3 2026, an estimated $54.3K.
Colgate-Palmolive made up 0.02% of Cetera Trust Company's portfolio in Q3 2026, its #234 holding.
Cetera Trust Company first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 12 quarters since.
Cetera Trust Company's Colgate-Palmolive position peaked at $104K in Q3 2024.
1,322 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Cetera Trust Company's 13F filing for Q3 2026, filed 9 Nov 2026.